Reported about 17 hours ago
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) stands out among billionaire Glenn Russell Dubin's stock picks for its significant upside potential of 80.19%. The biotech firm, known for its RNA-targeted treatments, showcases promising growth with increased revenue and a strong pipeline, making it a compelling choice for long-term investors. As financial markets rebound, Ionis's innovative approach and strategic partnerships could yield substantial returns, positioning it as a key player in the evolving healthcare landscape.
Source: YAHOO